Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony, -- Ignore unavailable to you. Want to Upgrade?

To: TradeOfTheDay who wrote (33445)	4/28/1999 7:56:00 PM
From: Keith Lenart	Read Replies (1) \| Respond to of 122087

MEDJ -- That FDA approval doesn't guarantee they will turn a profit! This company's cash burn rate is almost laughable. Granted the news was good -- and probably genuinely warranted a price run up to around 2 or 2-1/2, but daytrader hype and MoMos took it up another $4 after that. Just remember that lack of liquidity is a double edged sword and very few shares (<1000) were short as of the last NASD report, so there is little or no "squeezability" here. Guess that was why the news of the FDA approval had such an immediate impact on their stock price eh?